Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores: Findings From the ORBIT-AF I and II Registries.
Patients from GARFIELD-AF were less likely to be white (63% vs 89% for ORBIT-AF I and 86% for ORBIT-AF II) or have coronary artery disease (19% vs 36% and 27%), but had similar stroke risk (85% CHA<sub>2</sub>DS<sub>2</sub>-VASc ≥2 vs 91% and 85%) and lower bleeding risk (11% with HAS-BLED ≥3 vs 24% and 15%).